NovaBridge Biosciences (NBP) Other Gross PP&E Adjustments (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$27.7 million as the latest value for Q4 2022.

  • Quarterly Other Gross PP&E Adjustments rose 8.19% to -$27.7 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$27.7 million through Dec 2022, up 8.19% year-over-year, with the annual reading at -$27.7 million for FY2022, 8.19% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2022 was -$27.7 million at NovaBridge Biosciences, up from -$30.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$2.3 million in Q4 2020, with the low at -$30.2 million in Q4 2021.
  • Average Other Gross PP&E Adjustments over 4 years is -$15.6 million, with a median of -$15.0 million recorded in 2019.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 1235.19% in 2021, then rose 8.19% in 2022.
  • Over 4 years, Other Gross PP&E Adjustments stood at -$2.3 million in 2019, then rose by 2.95% to -$2.3 million in 2020, then crashed by 1235.19% to -$30.2 million in 2021, then grew by 8.19% to -$27.7 million in 2022.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$27.7 million, -$30.2 million, and -$2.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.